2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow JIANYANG WANG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT Anlotinib - Locally Advanced Non-Small Cell Lung Cancer, Thoracic Radiotherapy | Phase 2 | Completed | JIANYANG WANG | 44 | 2024-01-01 | 2026-10-07 |
| The Effect of Prophylactic TPO Combined with BMS-IMRT to Esophageal Cancer Patients rhTPO - Esophageal Cancer, Intensity-modulated Radiation Therapy | Phase 2 | Completed | JIANYANG WANG | 32 | 2023-07-20 | 2025-01-24 |
Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Thrombocytopenia (1)
Chemoradiotherapy (1) · anlotinib (1)
China (2)